Companies House does not verify the accuracy of the information filed(link opens a new window)
Advanced company searchLink opens in new window

CAMBRIDGE MEDICAL TECHNOLOGIES LIMITED

Company number 09237671

Follow this company File for this company
Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
03 Sep 2019 SH01 Statement of capital following an allotment of shares on 27 June 2019
  • GBP 334.473
23 Aug 2019 AA Group of companies' accounts made up to 31 December 2018
31 Jul 2019 RESOLUTIONS Resolutions
  • RES11 ‐ Resolution of removal of pre-emption rights
  • RES10 ‐ Resolution of allotment of securities
30 Jul 2019 SH01 Statement of capital following an allotment of shares on 21 June 2019
  • GBP 332.617
02 Jul 2019 RESOLUTIONS Resolutions
  • RES11 ‐ Resolution of removal of pre-emption rights
  • RES10 ‐ Resolution of allotment of securities
26 Jun 2019 RESOLUTIONS Resolutions
  • RES10 ‐ Resolution of allotment of securities
24 Jun 2019 SH01 Statement of capital following an allotment of shares on 5 April 2019
  • GBP 324.077
16 Feb 2019 TM01 Termination of appointment of Lindsay George Dibden as a director on 13 February 2019
14 Nov 2018 SH01 Statement of capital following an allotment of shares on 18 October 2018
  • GBP 319.835
14 Nov 2018 RESOLUTIONS Resolutions
  • RES11 ‐ Resolution of removal of pre-emption rights
  • RES10 ‐ Resolution of allotment of securities
23 Oct 2018 SH01 Statement of capital following an allotment of shares on 3 August 2018
  • GBP 310.435
05 Oct 2018 CS01 Confirmation statement made on 26 September 2018 with updates
04 Oct 2018 AA Group of companies' accounts made up to 31 December 2017
26 Jul 2018 PSC04 Change of details for Mr Emil Frederick Jachmann as a person with significant control on 25 July 2018
12 Jul 2018 SH01 Statement of capital following an allotment of shares on 29 June 2018
  • GBP 309.204
11 Jul 2018 RESOLUTIONS Resolutions
  • RES11 ‐ Resolution of removal of pre-emption rights
  • RES10 ‐ Resolution of allotment of securities
09 Oct 2017 SH01 Statement of capital following an allotment of shares on 22 August 2017
  • GBP 303.144
09 Oct 2017 CS01 Confirmation statement made on 26 September 2017 with updates
18 Jul 2017 AA Accounts for a dormant company made up to 30 September 2016
06 Feb 2017 AA01 Current accounting period extended from 30 September 2017 to 31 December 2017
06 Feb 2017 AP01 Appointment of Mr James Cornelius as a director on 2 February 2017
03 Feb 2017 AP01 Appointment of Mr Lindsay George Dibden as a director on 2 February 2017
22 Jan 2017 SH01 Statement of capital following an allotment of shares on 29 December 2016
  • GBP 287.728
19 Jan 2017 SH01 Statement of capital following an allotment of shares on 23 December 2016
  • GBP 250
19 Jan 2017 SH02 Sub-division of shares on 23 December 2016